1
/
of
0
FDA Adverse Event Reports by Hims & Hers – Semaglutide and Tirzepatide (Jan–Mar 2025)
FDA Adverse Event Reports by Hims & Hers – Semaglutide and Tirzepatide (Jan–Mar 2025)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: Please provide me with data on the adverse events reported to the FDA by Hims & Hers Health for compounded semaglutide and/or tirzepatide injections between January 1, 2025 and March 19, 2025.
Tags: Pharma, Adverse Event, 2025
Tags: Pharma, Adverse Event, 2025
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details